Allergic diseases include anaphylaxis, food allergies, forms of asthma, conjunctivitis, eczema, eosinophilic disorders, and drug and insect allergies. According to the International Study of Asthma and Allergies in Childhood (ISAAC), an estimated hay fever prevalence in the age group between 13 and 14 years was approximately 22.1%, globally, with 29.5% in Africa, 23.9% in Asia, 15.8% in the Indian subcontinent, 23.7% in Latin America, 33.3% in North America, 12.3% in Northern and Eastern Europe, 39.8% in Oceania, and 21.2% in Western Europe, in 2017. It is essential for patients to receive an accurate diagnosis of hay fever. Moreover, food allergies are on the rise.

An estimated 17 million Europeans have food allergies, and according to the European Academy of Allergy and Clinical Immunology (EAACI), over the past decade, hospital admissions for severe allergic reactions in children have risen seven-fold. Therefore, with the growing incidences of allergic diseases, the new diagnostic market for the same is expected to grow at a significant pace. Furthermore, the latest diagnostic strategies for allergies and researches on new approaches for treatment are expected to drive the market studied.

Key Market Trends

Inhaled Allergens Segment Captures the Largest Market Share

  • Allergens are of various types, such as consumed, ingested, contact, and inhaled. Of these, the inhaled allergens hold the largest share, as it is the most common among all the allergens.
  • Some of the most common symptoms of allergy, due to inhaled allergens, are itchy eyes, sneezing, watery eyes, etc. The rising pollution in the environment, coupled with the changing lifestyle of the people, is boosting the segment’s growth.
  • On the other hand, food allergens still remain to exhibit the fastest growth rate, owing to the unawareness among the individuals regarding certain food allergies, thereby, propelling the market growth.



North America Captured the Largest Market Share and is Expected to Retain its Dominance

  • North America is currently the largest market for allergic diagnostics, globally, in terms of value, and occupies the major share of the global market. The large market size of the North American market is mainly due to the United States, which represents more than 80% of the North American market share.
  • There are several factors that make the United States the largest market for allergy diagnostics, such as high awareness toward allergies among the population, better regulatory guidelines that mandate allergic testing in all cases of intensive and emergency care, and better healthcare infrastructure to deal with patients’ allergic situations. General allergy testing is also very high in the United States, approximately one in six Americans (around 50 million) suffer from some form of allergy and approximately 25 million Americans suffer from respiratory allergies.



Competitive Landscape

The presence of major market players, such as bioMerieux, Danaher Corporation, Omega Diagnostics, Siemens Healthineers AG, and Thermo Fischer Scientific, is intensifying the market competition. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the world. In 2019, AllerGenis introduced ’Luminex xMap Technology’, for the diagnosis of food allergies in patients.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support